Literature DB >> 17523050

Cytochrome P450 probe substrate metabolism kinetics in Sprague Dawley rats.

J P Chovan1, S C Ring, E Yu, J P Baldino.   

Abstract

The objective of the current study was to investigate the metabolism of cytochrome P450 (CYP) probe substrates in male Sprague Dawley rat liver microsomes and to determine their substrate specificities. Time and microsomal protein concentrations were varied to determine the linear conditions for each reaction. Appropriate substrate concentrations were chosen to determine the apparent K(m) and V(max) for 17 different reactions under initial rate conditions of protein and reaction time. All reactions appeared to follow Michaelis-Menten kinetics. Subsequently, each substrate was incubated at one to two times K(m) with each of 14 baculovirus cDNA-expressed rat CYP enzymes to determine the specificity of the reaction monitored. Of the 14 enzymes tested, seven were seen as the major rat CYP enzymes responsible for the majority of the substrate metabolism tested. Testosterone 2alpha- and 16alpha-hydroxylation reactions were conducted primarily by CYP2C11, and midazolam 4-hydroxylation and triazolam 1'-hydroxylation were preferentially catalyzed by CYP3A1/2, but specificity was otherwise generally poor. The results presented herein clearly indicate that care must be taken in interpretation of metabolism results obtained in rats using standard probe substrates, especially in extrapolation of those results to humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17523050     DOI: 10.1080/00498250701245250

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  7 in total

1.  A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats.

Authors:  Liang Li; Zai-quan Li; Chen-hui Deng; Miao-ran Ning; Han-qing Li; Shan-shan Bi; Tian-yan Zhou; Wei Lu
Journal:  Acta Pharmacol Sin       Date:  2012-01       Impact factor: 6.150

2.  Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease.

Authors:  D A Feere; T J Velenosi; B L Urquhart
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

3.  Pulmonary Metabolism of Substrates for Key Drug-Metabolizing Enzymes by Human Alveolar Type II Cells, Human and Rat Lung Microsomes, and the Isolated Perfused Rat Lung Model.

Authors:  Katarina Rubin; Pär Ewing; Erica Bäckström; Anna Abrahamsson; Britta Bonn; Satoshi Kamata; Ken Grime
Journal:  Pharmaceutics       Date:  2020-02-01       Impact factor: 6.321

4.  Chemical Characterisation and Antihypertensive Effects of Locular Gel and Serum of Lycopersicum esculentum L. var. "Camone" Tomato in Spontaneously Hypertensive Rats.

Authors:  Paola Marcolongo; Alessandra Gamberucci; Gabriella Tamasi; Alessio Pardini; Claudia Bonechi; Claudio Rossi; Roberta Giunti; Virginia Barone; Annalisa Borghini; Paolo Fiorenzani; Maria Frosini; Massimo Valoti; Federica Pessina
Journal:  Molecules       Date:  2020-08-18       Impact factor: 4.411

5.  Screening Ingredients from Herbs against Pregnane X Receptor in the Study of Inductive Herb-Drug Interactions: Combining Pharmacophore and Docking-Based Rank Aggregation.

Authors:  Zhijie Cui; Hong Kang; Kailin Tang; Qi Liu; Zhiwei Cao; Ruixin Zhu
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

6.  A small-animal pharmacokinetic/pharmacodynamic PET study of central serotonin 1A receptor occupancy by a potential therapeutic agent for overactive bladder.

Authors:  Yosuke Nakatani; Michiyuki Suzuki; Masaki Tokunaga; Jun Maeda; Miyuki Sakai; Hiroki Ishihara; Takashi Yoshinaga; Osamu Takenaka; Ming-Rong Zhang; Tetsuya Suhara; Makoto Higuchi
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

7.  Effects of berberine on pharmacokinetics of midazolam and rhodamine 123 in rats in vivo.

Authors:  Hua-Wen Xin; Xia Tang; Meng Ouyang; Jian-Xun Zhong; Wei-Liang Li
Journal:  Springerplus       Date:  2016-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.